TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy.

The EMBO Journal
Kautilya Kumar JenaSantosh Chauhan

Abstract

Sequestration of protein aggregates in inclusion bodies and their subsequent degradation prevents proteostasis imbalance, cytotoxicity, and proteinopathies. The underlying molecular mechanisms controlling the turnover of protein aggregates are mostly uncharacterized. Herein, we show that a TRIM family protein, TRIM16, governs the process of stress-induced biogenesis and degradation of protein aggregates. TRIM16 facilitates protein aggregate formation by positively regulating the p62-NRF2 axis. We show that TRIM16 is an integral part of the p62-KEAP1-NRF2 complex and utilizes multiple mechanisms for stabilizing NRF2. Under oxidative and proteotoxic stress conditions, TRIM16 activates ubiquitin pathway genes and p62 via NRF2, leading to ubiquitination of misfolded proteins and formation of protein aggregates. We further show that TRIM16 acts as a scaffold protein and, by interacting with p62, ULK1, ATG16L1, and LC3B, facilitates autophagic degradation of protein aggregates. Thus, TRIM16 streamlines the process of stress-induced aggregate clearance and protects cells against oxidative/proteotoxic stress-induced toxicity in vitro and in vivo Taken together, this work identifies a new mechanism of protein aggregate turnover, which c...Continue Reading

References

Dec 29, 1998·The Journal of Cell Biology·J A JohnstonR R Kopito
Sep 5, 2002·Cell Motility and the Cytoskeleton·Jennifer A JohnstonRon R Kopito
Nov 25, 2003·The Journal of Biological Chemistry·Mikiei TanakaM Maral Mouradian
Sep 2, 2004·Molecular and Cellular Biology·M Lamar SeibenhenerMarie W Wooten
Nov 3, 2004·Trends in Molecular Medicine·Hozumi Motohashi, Masayuki Yamamoto
Sep 22, 2005·Nature Reviews. Microbiology·Sébastien NisoleAli Saïb
Dec 22, 2006·The Journal of Biological Chemistry·Sovan SarkarDavid C Rubinsztein
Mar 3, 2007·Cell Death and Differentiation·M KomatsuK Tanaka
Jun 21, 2007·The Journal of Biological Chemistry·Serhiy PankivTerje Johansen
Jan 29, 2008·Current Medicinal Chemistry·J A OlzmannL S Chin
May 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Peter M DouglasDouglas M Cyr
Nov 19, 2008·Journal of Clinical Biochemistry and Nutrition·Noriko Noguchi
May 20, 2009·Molecular Cell·Vladimir KirkinIvan Dikic
Apr 10, 2010·The Journal of Biological Chemistry·Ian M CoppleB Kevin Park
Sep 3, 2010·Nature Cell Biology·Claudine KraftKay Hofmann
Oct 15, 2010·Nature Reviews. Molecular Cell Biology·Jens TyedmersBernd Bukau
Dec 30, 2010·Autophagy·Terje Johansen, Trond Lamark
Jan 5, 2011·Lipids in Health and Disease·Kuniaki HiroseHiroyuki Daida
Jan 22, 2011·Autophagy·Brigit E RileyRon R Kopito
Mar 30, 2011·Nature Chemical Biology·Jie XuJoost Schymkowitz
Jul 13, 2011·Cold Spring Harbor Perspectives in Biology·Bryan ChenJudith Frydman
Sep 23, 2011·Nucleic Acids Research·Santosh Chauhan, Douglas D Boyd
Apr 21, 2012·International Journal of Cell Biology·Trond Lamark, Terje Johansen

❮ Previous
Next ❯

Citations

Jul 10, 2019·Journal of Experimental & Clinical Cancer Research : CR·Biswajit Das, Shantibhusan Senapati
Sep 25, 2019·International Journal of Molecular Sciences·Daniela Bender, Eberhard Hildt
Jan 22, 2020·Journal of Periodontal Research·Kübra AralPaul R Cooper
Jun 6, 2020·Antioxidants·Ana Martin-HurtadoFrancesc R Garcia-Gonzalo
Sep 3, 2020·Proceedings of the National Academy of Sciences of the United States of America·Daniel SilvermanKing-Wai Yau
Feb 6, 2020·Cells·Sandeep MalampatiAnd Min Li
Apr 1, 2020·Frontiers in Pharmacology·Michael A MandellTodd A Thompson
Jul 28, 2020·Pharmaceuticals·Angel Escamilla-RamírezCristina Trejo-Solís
Jan 24, 2020·Cell Death and Differentiation·Martina Di RienzoGian Maria Fimia
Apr 24, 2020·Cancer Cell International·Xiao-Yu YanJing Su
Sep 29, 2020·Frontiers in Cell and Developmental Biology·Litian ZhangLiang Chen
Apr 15, 2020·Antimicrobial Agents and Chemotherapy·Arnau BioscaXavier Fernàndez-Busquets
Dec 2, 2020·Journal of Personalized Medicine·Christina VasilopoulouWilliam Duddy
Aug 24, 2020·Current Opinion in Microbiology·Lennart KoepkeKonstantin Mj Sparrer
Jan 14, 2021·Cell Biology International·Tingting WanYanbo Li
Mar 26, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaohui SuNa Lin
Dec 5, 2020·Matrix Biology : Journal of the International Society for Matrix Biology·Fumiyo Ikeda

❮ Previous
Next ❯

Methods Mentioned

BETA
environmental stresses
nuclear translocation
Fluorescence
Immunoprecipitation
ubiquitination
xenograft

Software Mentioned

ProteoStat
ImageJ
IP

Related Concepts

Related Feeds

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.